1 – 10 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Risk of estrogen receptor-specific breast cancer by family history of estrogen receptor subtypes and other cancers
(
- Contribution to journal › Article
-
Mark
Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden
(
- Contribution to journal › Article
- 2022
-
Mark
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes : Pooled Analysis of Population-Based Studies
(
- Contribution to journal › Article
- 2017
-
Mark
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
(
- Contribution to journal › Article
- 2016
-
Mark
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
(
- Contribution to journal › Article
-
Mark
Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera
(
- Contribution to journal › Article
-
Mark
PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia
(
- Contribution to journal › Article
- 2014
-
Mark
Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium
(
- Contribution to journal › Article
-
Mark
Longitudinal neurochemical modifications in the aging mouse brain measured in vivo by 1H magnetic resonance spectroscopy
(
- Contribution to journal › Article
- 2012
-
Mark
Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer
(
- Contribution to journal › Article